Ignite Creation Date:
2025-12-24 @ 9:18 PM
Ignite Modification Date:
2026-01-03 @ 11:59 PM
Study NCT ID:
NCT02710604
Status:
COMPLETED
Last Update Posted:
2017-09-13
First Post:
2016-03-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2, Multiple Ascending Dose Proof of Concept Study
Sponsor:
ContraVir Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
UNKNOWN
Study ID:
CTRV-CMX157-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None